BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27507557)

  • 1. Maintenance of the EBV-specific CD8
    Nguyen TH; Bird NL; Grant EJ; Miles JJ; Thomas PG; Kotsimbos TC; Mifsud NA; Kedzierska K
    Immunol Cell Biol; 2017 Jan; 95(1):77-86. PubMed ID: 27507557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDR3α drives selection of the immunodominant Epstein Barr virus (EBV) BRLF1-specific CD8 T cell receptor repertoire in primary infection.
    Kamga L; Gil A; Song I; Brody R; Ghersi D; Aslan N; Stern LJ; Selin LK; Luzuriaga K
    PLoS Pathog; 2019 Nov; 15(11):e1008122. PubMed ID: 31765434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired.
    Cárdenas D; Vélez G; Orfao A; Herrera MV; Solano J; Olaya M; Uribe AM; Saavedra C; Duarte M; Rodríguez M; López M; Fiorentino S; Quijano S
    Clin Exp Immunol; 2015 Nov; 182(2):173-83. PubMed ID: 26174440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Epstein-Barr virus-specific CD8+ T lymphocytes in the circulation of pediatric transplant recipients.
    Falco DA; Nepomuceno RR; Krams SM; Lee PP; Davis MM; Salvatierra O; Alexander SR; Esquivel CO; Cox KL; Frankel LR; Martinez OM
    Transplantation; 2002 Aug; 74(4):501-10. PubMed ID: 12352909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune reconstitution of HLA-A*0201/BMLF1- and HLA-A*1101/LMP2-specific Epstein Barr virus cytotoxic T lymphocytes within 90 days after haploidentical hematopoietic stem cell transplantation.
    Zhou L; Lu DP
    Virol J; 2019 Feb; 16(1):19. PubMed ID: 30736814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr Virus Epitope-Major Histocompatibility Complex Interaction Combined with Convergent Recombination Drives Selection of Diverse T Cell Receptor α and β Repertoires.
    Gil A; Kamga L; Chirravuri-Venkata R; Aslan N; Clark F; Ghersi D; Luzuriaga K; Selin LK
    mBio; 2020 Mar; 11(2):. PubMed ID: 32184241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection.
    Silins SL; Cross SM; Elliott SL; Pye SJ; Burrows JM; Moss DJ; Misko IS
    Int Immunol; 1997 Nov; 9(11):1745-55. PubMed ID: 9418135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of T-Cell Multifunctionality and TCR-Vβ Repertoire Against Epstein-Barr Virus Is Associated With Worse Prognosis and Clinical Parameters in HIV
    Hernández DM; Valderrama S; Gualtero S; Hernández C; López M; Herrera MV; Solano J; Fiorentino S; Quijano S
    Front Immunol; 2018; 9():2291. PubMed ID: 30337929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adequate control of primary EBV infection and subsequent reactivations after cardiac transplantation in an EBV seronegative patient.
    Pietersma FL; van Oosterom A; Ran L; Schuurman R; Meijer E; de Jonge N; van Baarle D
    Transpl Immunol; 2012 Aug; 27(1):48-51. PubMed ID: 22342937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skewed T cell responses to Epstein-Barr virus in long-term asymptomatic kidney transplant recipients.
    Nakid-Cordero C; Arzouk N; Gauthier N; Tarantino N; Larsen M; Choquet S; Burrel S; Autran B; Vieillard V; Guihot A
    PLoS One; 2019; 14(10):e0224211. PubMed ID: 31639143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late diversification in the clonal composition of human cytomegalovirus-specific CD8+ T cells following allogeneic hemopoietic stem cell transplantation.
    Gandhi MK; Wills MR; Okecha G; Day EK; Hicks R; Marcus RE; Sissons JG; Carmichael AJ
    Blood; 2003 Nov; 102(9):3427-38. PubMed ID: 12869514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time.
    Iancu EM; Corthesy P; Baumgaertner P; Devevre E; Voelter V; Romero P; Speiser DE; Rufer N
    J Immunol; 2009 Jul; 183(1):319-31. PubMed ID: 19542443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
    Hosseini-Moghaddam SM; Alhomayeed B; Soliman N; Weir MA; House AA
    Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation.
    Marshall NA; Howe JG; Formica R; Krause D; Wagner JE; Berliner N; Crouch J; Pilip I; Cooper D; Blazar BR; Seropian S; Pamer EG
    Blood; 2000 Oct; 96(8):2814-21. PubMed ID: 11023516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal analysis of frequency and reactivity of Epstein-Barr virus-specific T lymphocytes and their association with intermittent viral reactivation.
    Vogl BA; Fagin U; Nerbas L; Schlenke P; Lamprecht P; Jabs WJ
    J Med Virol; 2012 Jan; 84(1):119-31. PubMed ID: 22095540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overall avidity declines in TCR repertoires during latent CMV but not EBV infection.
    Couturaud B; Doix B; Carretero-Iglesia L; Allard M; Pradervand S; Hebeisen M; Rufer N
    Front Immunol; 2023; 14():1293090. PubMed ID: 38053994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining virological, serological and immunological parameters of EBV infection in the development of PTLD.
    Davis JE; Sherritt MA; Bharadwaj M; Morrison LE; Elliott SL; Kear LM; Maddicks-Law J; Kotsimbos T; Gill D; Malouf M; Falk MC; Khanna R; Moss DJ
    Int Immunol; 2004 Jul; 16(7):983-9. PubMed ID: 15159377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EBV-specific memory CD8+ T cell phenotype and function in stable solid organ transplant patients.
    Macedo C; Donnenberg A; Popescu I; Reyes J; Abu-Elmagd K; Shapiro R; Zeevi A; Fung JJ; Storkus WJ; Metes D
    Transpl Immunol; 2005 Jun; 14(2):109-16. PubMed ID: 15935301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative and functional diversity of cross-reactive EBV-specific CD8+ T cells in a longitudinal study cohort of lung transplant recipients.
    Mifsud NA; Nguyen TH; Tait BD; Kotsimbos TC
    Transplantation; 2010 Dec; 90(12):1439-49. PubMed ID: 21042237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.